Good morning :)
Switch to
Add to Watchlist

Nifty Pharma Index

NIFTY PHARMA
INDEX
IndexPharma
SectoralThis index consists of sector specific companies
Low RiskIndex is 0.86x as volatile as Nifty
14,097.25257.90 (-1.80%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
IndexPharma
SectoralThis index consists of sector specific companies
Low RiskIndex is 0.86x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
35.03
PB RatioPB Ratio
5.87
Dividend YieldDiv. Yield
0.60%
Market Cap ShareM Cap Share
2.75%
ConstituentsConstituents
10
ETFsETFs

About Index

The NIFTY Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.

Get more out of Tickertape, Go Pro!

Unlock exclusive stocks’ data & unlimited access with Tickertape Pro

See Plans

Recent EventsAll events 

Analysts/Institutional Investor Meet/Con. Call Updates AUROPHARMA
Announced OnSep 20, 2021

Aurobindo Pharma Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates | Download

Aurobindo Pharma Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates | Download

Updates CADILAHC
Announced OnSep 20, 2021

Cadila Healthcare Limited has informed the Exchange regarding 'Zydus Healthcare Limited, a wholly owned subsidiary of the Company has entered into an agreement today i.e. September 20, 2021 with Integrace Private Limited ( Purchaser ) to sell two brands viz. Mifegest and Cytolog.'. | Download

Cadila Healthcare Limited has informed the Exchange regarding 'Zydus Healthcare Limited, a wholly owned subsidiary of the Company has entered into an agreement today i.e. September 20, 2021 with Integrace Private Limited ( Purchaser ) to sell two brands viz. Mifegest and Cytolog.'. | Download

Cash Dividend AUROPHARMA
Ex. DateAug 27, 2021

Interim • Div/Share: ₹ 1.5

See all events